(1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane

C23H32N4O — CID 72882613

IUPAC(1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane
SMILESC=CCn1ncc(CN2C[C@H]3CC[C@@H]2CN(Cc2ccc(OC)cc2)C3)c1C
InChIInChI=1S/C23H32N4O/c1-4-11-27-18(2)21(12-24-27)16-26-15-20-5-8-22(26)17-25(14-20)13-19-6-9-23(28-3)10-7-19/h4,6-7,9-10,12,20,22H,1,5,8,11,13-17H2,2-3H3/t20-,22+/m0/s1
InChIKeyFIEJRHOQUZDWLY-RBBKRZOGSA-N
MW380.54 g/mol
LogP3.48
Rot. Bonds7

About (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane

(1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane (PubChem CID 72882613) has the molecular formula C23H32N4O and a molecular weight of 380.54 g/mol. Its IUPAC name is (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane.

Molecular Properties

Compound Name(1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane
PubChem CID72882613
Molecular FormulaC23H32N4O
Molecular Weight380.54 g/mol
Exact Mass380.26
IUPAC Name(1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane
SMILESC=CCn1ncc(CN2C[C@H]3CC[C@@H]2CN(Cc2ccc(OC)cc2)C3)c1C
InChIInChI=1S/C23H32N4O/c1-4-11-27-18(2)21(12-24-27)16-26-15-20-5-8-22(26)17-25(14-20)13-19-6-9-23(28-3)10-7-19/h4,6-7,9-10,12,20,22H,1,5,8,11,13-17H2,2-3H3/t20-,22+/m0/s1
InChIKeyFIEJRHOQUZDWLY-RBBKRZOGSA-N
XLogP3.48
TPSA33.53 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500380.54
LogP ≤ 53.48
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane?
The IUPAC name of (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane (CID 72882613) is (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane.
What is the SMILES notation for (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane?
The canonical SMILES for (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane is C=CCn1ncc(CN2C[C@H]3CC[C@@H]2CN(Cc2ccc(OC)cc2)C3)c1C.
What is the InChIKey of (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane?
The InChIKey is FIEJRHOQUZDWLY-RBBKRZOGSA-N. The full InChI is InChI=1S/C23H32N4O/c1-4-11-27-18(2)21(12-24-27)16-26-15-20-5-8-22(26)17-25(14-20)13-19-6-9-23(28-3)10-7-19/h4,6-7,9-10,12,20,22H,1,5,8,11,13-17H2,2-3H3/t20-,22+/m0/s1.
What are the key properties of (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane?
(1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane has a molecular weight of 380.54 g/mol, XLogP of 3.48, 7 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (1S,5R)-3-[(4-methoxyphenyl)methyl]-6-[(5-methyl-1-prop-2-enylpyrazol-4-yl)methyl]-3,6-diazabicyclo[3.2.2]nonane is sourced from PubChem (CID 72882613), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).